TY - JOUR
T1 - Biomarker Discovery and Validation
T2 - Statistical Considerations
AU - Ou, Fang Shu
AU - Michiels, Stefan
AU - Shyr, Yu
AU - Adjei, Alex A.
AU - Oberg, Ann L.
N1 - Funding Information:
This work was partially supported by the National Institutes of Health (NIH) grant P30CA15083 (Mayo Comprehensive Cancer Center grant; Drs. Ou, Oberg, and Adjei), National Cancer Institute (NCI) grant P50CA136393 ( Mayo Clinic Specialized Programs of Research Excellence in Ovarian Cancer grant; Dr. Oberg), NCI grant P50CA102701 (Mayo Clinic Specialized Programs of Research Excellence in Pancreatic Cancer; Dr. Oberg), NCI grant U10CA180882 (Alliance Statistics and Data Management Center; Drs. Ou and Oberg), NIH grant U24CA213274 (Dr. Shyr), NIH grant U54TR002243 (Dr. Shyr), and NIH grant P30CA068485 (Dr. Shyr)
Publisher Copyright:
© 2021 International Association for the Study of Lung Cancer
PY - 2021/4
Y1 - 2021/4
N2 - Biomarkers have various applications including disease detection, diagnosis, prognosis, prediction of response to intervention, and disease monitoring. In this era of precision medicine, having validated biomarkers to inform clinical decision making is more important than ever. In this article, we discuss best the practices and potential issues in biomarker discovery and validation. We encourage team science partnerships to bring cutting-edge discovery from bench to bedside, leading to improved patient care and outcomes.
AB - Biomarkers have various applications including disease detection, diagnosis, prognosis, prediction of response to intervention, and disease monitoring. In this era of precision medicine, having validated biomarkers to inform clinical decision making is more important than ever. In this article, we discuss best the practices and potential issues in biomarker discovery and validation. We encourage team science partnerships to bring cutting-edge discovery from bench to bedside, leading to improved patient care and outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85101357100&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101357100&partnerID=8YFLogxK
U2 - 10.1016/j.jtho.2021.01.1616
DO - 10.1016/j.jtho.2021.01.1616
M3 - Article
C2 - 33545385
AN - SCOPUS:85101357100
VL - 16
SP - 537
EP - 545
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
SN - 1556-0864
IS - 4
ER -